New PET scan agent could spot hidden tumors better
NCT ID NCT04888481
First seen May 12, 2026 · Last updated May 16, 2026 · Updated 3 times
Summary
This study tests a new radioactive tracer called 68Ga-HA-DOTATATE for PET/CT scans in people with known or suspected neuroendocrine tumors. The goal is to see if it is safe and more accurate than older imaging methods. About 600 participants will be enrolled to measure how well the scan detects tumors compared to follow-up over one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Alberta
RECRUITINGEdmonton, Alberta, T6G 2B7, Canada
Contact
Conditions
Explore the condition pages connected to this study.